Ann Miller
Director/Board Member chez INOVIO PHARMACEUTICALS, INC.
Fortune : 76 951 $ au 31/03/2024
Profil
Ann Calby Miller is an Independent Director at Inovio Pharmaceuticals, Inc. and Allena Pharmaceuticals, Inc. She previously worked as an Executive Director-Global Marketing at Amgen, Inc., Senior Vice President-Pharmaceutical Services at Eisai Co., Ltd., Vice President-Marketing & Global Marketing at Sanofi SA, and as an Independent Director at Puma Biotechnology, Inc. She received her undergraduate degree from Duke University and her doctorate from Duke University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/11/2023 | 5 544 ( 0,02% ) | 76 951 $ | 31/03/2024 |
Postes actifs de Ann Miller
| Sociétés | Poste | Début |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 25/03/2019 |
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 05/10/2020 |
Anciens postes connus de Ann Miller
| Sociétés | Poste | Fin |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Director/Board Member | 31/12/2021 |
| Sanofi SA | Sales & Marketing | 01/09/2018 |
| EISAI CO., LTD. | Corporate Officer/Principal | 01/01/2011 |
| AMGEN INC. | Sales & Marketing | 01/01/2007 |
Formation de Ann Miller
| Duke University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| AMGEN INC. | Health Technology |
| EISAI CO., LTD. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Sanofi SA | Health Technology |
